CARA THERAPEUTICS INC (CARA)

US1407551092 - Common Stock

0.7071  -0.02 (-3.19%)

After market: 0.7071 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
20.97M41.90M23.00M135.10M19.90M
Cost Of Goods
6.17M7.30MN/AN/AN/A
Gross Profit
14.79M34.60MN/AN/AN/A
Operating Expenses
136.29M122.10M112.10M129.70M131.60M
Research and Development
108.38M91.80M82.60M107.70M113.70M
Selling, General, and Administrative Expenses
27.65M30.10M29.30M21.70M17.70M
Operating Income
-121.50M-87.50M-89.10M5.40M-111.70M
Interest Income/Expense
3.59M2.10M600.00K2.30M4.50M
Other Income/Expense
-604.00KN/AN/AN/AN/A
Income Before Taxes
-118.51M-85.50M-88.40M7.70M-107.20M
Income Tax
N/A0.000.00-700.00K-800.00K
Net Income
-118.51M-85.50M-88.40M8.40M-106.40M
EBITDA
-121.24M-87.25M-88.85M5.61M-111.50M
 
Per Share Data
EPS Diluted Total Ops
-2.19-1.59-1.740.18-2.49
Non GAAP EPS
-2.18-1.59-1.730.08-2.49
 
Statistics
Gross Profit Margin
70.56%82.58%N/AN/AN/A
Profit Margin
-565.21%-204.06%-384.35%6.22%-534.67%
Operating Profit Margin
-579.43%-208.83%-387.39%4.00%-561.31%

All data in USD

Charts